NZ592686A - Process for the preparation of vorinostat from aniline, hydroxylamine and suberic acid starting materials - Google Patents
Process for the preparation of vorinostat from aniline, hydroxylamine and suberic acid starting materialsInfo
- Publication number
- NZ592686A NZ592686A NZ592686A NZ59268609A NZ592686A NZ 592686 A NZ592686 A NZ 592686A NZ 592686 A NZ592686 A NZ 592686A NZ 59268609 A NZ59268609 A NZ 59268609A NZ 592686 A NZ592686 A NZ 592686A
- Authority
- NZ
- New Zealand
- Prior art keywords
- hydroxylamine
- aniline
- vorinostat
- salt
- suberic acid
- Prior art date
Links
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 title abstract 6
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 title abstract 6
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 title abstract 5
- 229960000237 vorinostat Drugs 0.000 title abstract 4
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000007858 starting material Substances 0.000 title 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 abstract 4
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 abstract 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N 1,1'-Carbonyldiimidazole Substances C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 abstract 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 abstract 2
- YNBDVONJRSJFLP-UHFFFAOYSA-N 8-(hydroxyamino)-8-oxooctanoic acid Chemical compound ONC(=O)CCCCCCC(O)=O YNBDVONJRSJFLP-UHFFFAOYSA-N 0.000 abstract 2
- PAXDAFSGJPGLGR-UHFFFAOYSA-N 8-anilino-8-oxooctanoic acid Chemical compound OC(=O)CCCCCCC(=O)NC1=CC=CC=C1 PAXDAFSGJPGLGR-UHFFFAOYSA-N 0.000 abstract 2
- 239000007822 coupling agent Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1746KO2008 | 2008-10-15 | ||
| PCT/GB2009/051376 WO2010043904A2 (en) | 2008-10-15 | 2009-10-14 | Improved process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ592686A true NZ592686A (en) | 2012-12-21 |
Family
ID=41822438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ592686A NZ592686A (en) | 2008-10-15 | 2009-10-14 | Process for the preparation of vorinostat from aniline, hydroxylamine and suberic acid starting materials |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8883851B2 (enExample) |
| EP (1) | EP2349985A2 (enExample) |
| JP (1) | JP5769627B2 (enExample) |
| CN (1) | CN102264694B (enExample) |
| AU (1) | AU2009305214B2 (enExample) |
| CA (1) | CA2740559C (enExample) |
| NZ (1) | NZ592686A (enExample) |
| WO (1) | WO2010043904A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1391812B1 (it) * | 2008-07-29 | 2012-01-27 | Maria Grazia Rimoli | Profarmaco galattosilato del ketorolac ad uso analgesico e antinfiammatorio con migliori caratteristiche farmacocinetiche e profilo tossicologico del farmaco di partenza |
| NZ593585A (en) * | 2008-11-26 | 2012-12-21 | Generics Uk Ltd | Crystalline forms of vorinostat (suberoylanilide hydroxamic acid) |
| WO2011061545A1 (en) | 2009-11-23 | 2011-05-26 | Generics [Uk] Limited | Hplc method for analyzing vorinostat |
| US20110313044A1 (en) * | 2010-06-18 | 2011-12-22 | Urquima S.A. | Polymorphs of Suberoylanilide Hydroxamic Acid |
| CN103018346A (zh) * | 2011-09-20 | 2013-04-03 | 北京本草天源药物研究院 | 伏立诺他及其药物组合物中的杂质的高效液相色谱分析方法 |
| CN104693071A (zh) * | 2013-12-04 | 2015-06-10 | 山东新时代药业有限公司 | 一种n- 羟基-n’- 苯基辛二酰胺制备方法 |
| CN103922967B (zh) * | 2014-04-15 | 2016-06-01 | 北京化工大学 | 一种异羟肟酸类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用 |
| CN104292133B (zh) * | 2014-09-29 | 2016-06-01 | 烟台市华文欣欣医药科技有限公司 | 一种抗癌药物伏立诺他的合成方法 |
| CN104649925A (zh) * | 2015-02-13 | 2015-05-27 | 山东新时代药业有限公司 | 一种伏立诺他中间体的制备方法 |
| CN105259261A (zh) * | 2015-10-09 | 2016-01-20 | 扬子江药业集团江苏海慈生物药业有限公司 | 一种药物中苯胺含量的测定方法 |
| CN106187818B (zh) * | 2016-06-27 | 2017-12-08 | 刘美新 | 一种制备抗癌药物伏立诺他的方法 |
| CN106008267B (zh) * | 2016-06-27 | 2018-04-06 | 马腾 | 一种抗癌药物伏立诺他的制备方法 |
| WO2018160676A1 (en) * | 2017-03-01 | 2018-09-07 | University Of The Sciences | Compositions and methods for reactivating latent hiv-1 infections |
| TWI650139B (zh) | 2017-10-11 | 2019-02-11 | 行政院原子能委員會核能硏究所 | 含有放射性同位素氟的異羥肟酸類造影劑、其製備方法及其用途 |
| CN109134313B (zh) * | 2018-10-16 | 2021-05-25 | 新昌县勤勉生物医药科技有限公司 | 一种利用改性介孔材料催化制备伏立诺他的方法 |
| CN110283102B (zh) * | 2019-05-31 | 2022-09-27 | 宿州亿帆药业有限公司 | 一种伏林司他ⅰ晶型的制备方法 |
| CN113943232A (zh) * | 2021-11-25 | 2022-01-18 | 汤斌 | 一种从大鲵肽中提取伏立诺他的方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5369108A (en) | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| GB9504084D0 (en) | 1995-03-01 | 1995-04-19 | British Biotech Pharm | Synthesis of carboxylic and hydroxamic acid derivatives |
| IT1283637B1 (it) | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
| US6497820B1 (en) | 1998-02-03 | 2002-12-24 | Arqule, Inc. | Rapid method for separation of small molecules using reverse phase high performance liquid chromatography |
| EP1233958B1 (en) | 1999-11-23 | 2011-06-29 | MethylGene Inc. | Inhibitors of histone deacetylase |
| US7456219B2 (en) * | 2002-03-04 | 2008-11-25 | Merck Hdac Research, Llc | Polymorphs of suberoylanilide hydroxamic acid |
| AU2003213684C1 (en) | 2002-03-04 | 2008-10-23 | Merck Hdac Research, Llc | Methods of inducing terminal differentiation |
| UA83065C2 (ru) * | 2003-08-26 | 2008-06-10 | МЕРК ЕйчДиЕйСи РІСЕРЧ, ЛЛС | Способ лечения мезотелиомы с использованием ингибитора hdac - субероиланилидгидроксаминовой кислоты (saha) |
| PL379887A1 (pl) | 2003-08-26 | 2006-11-27 | Merck Hdac Research, Llc | Sposób leczenia raka inhibitorami HDAC |
| EP1541549A1 (en) | 2003-12-12 | 2005-06-15 | Exonhit Therapeutics S.A. | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods |
| CN101080223B (zh) | 2005-05-20 | 2015-02-11 | 默沙东公司 | 辛二酰苯胺异羟肟酸制剂及其制备方法 |
| TWI415603B (zh) | 2005-05-20 | 2013-11-21 | Merck Sharp & Dohme | １，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法 |
| CN101516191A (zh) | 2006-09-28 | 2009-08-26 | 默克公司 | Saha的胺碱盐和其多晶型物 |
| EP2079462A4 (en) | 2006-09-28 | 2009-12-02 | Merck & Co Inc | PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELABLE METAL COMPOUNDS AND METALO HDAC HEMMER CHELATE COMPLEXES |
| US20110041589A1 (en) | 2007-12-14 | 2011-02-24 | Generics [Uk] Limited | New hpcl method |
| WO2009098515A1 (en) | 2008-02-07 | 2009-08-13 | Generics [Uk] Limited | Novel process for the preparation of vorinostat |
| US20090223286A1 (en) | 2008-02-13 | 2009-09-10 | Vandana Singh | Analytical method for determination of related substances of imipenem and cilastatin |
| CZ2008167A3 (cs) | 2008-03-14 | 2010-02-24 | Zentiva, A. S. | Specifické necistoty montelukastu |
| NZ593585A (en) | 2008-11-26 | 2012-12-21 | Generics Uk Ltd | Crystalline forms of vorinostat (suberoylanilide hydroxamic acid) |
| AU2009321385A1 (en) | 2008-11-26 | 2011-06-23 | Generics [Uk] Limited | Novel processes and pure polymorphs |
-
2009
- 2009-10-14 AU AU2009305214A patent/AU2009305214B2/en not_active Ceased
- 2009-10-14 NZ NZ592686A patent/NZ592686A/xx not_active IP Right Cessation
- 2009-10-14 CA CA2740559A patent/CA2740559C/en not_active Expired - Fee Related
- 2009-10-14 CN CN200980150218.2A patent/CN102264694B/zh not_active Expired - Fee Related
- 2009-10-14 EP EP09748455A patent/EP2349985A2/en not_active Withdrawn
- 2009-10-14 US US13/124,337 patent/US8883851B2/en active Active
- 2009-10-14 JP JP2011531571A patent/JP5769627B2/ja not_active Expired - Fee Related
- 2009-10-14 WO PCT/GB2009/051376 patent/WO2010043904A2/en not_active Ceased
-
2014
- 2014-10-06 US US14/506,741 patent/US9162974B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20150018424A1 (en) | 2015-01-15 |
| CN102264694A (zh) | 2011-11-30 |
| US20110263712A1 (en) | 2011-10-27 |
| US8883851B2 (en) | 2014-11-11 |
| JP5769627B2 (ja) | 2015-08-26 |
| EP2349985A2 (en) | 2011-08-03 |
| CA2740559C (en) | 2016-02-16 |
| AU2009305214B2 (en) | 2015-06-25 |
| AU2009305214A1 (en) | 2010-04-22 |
| US9162974B2 (en) | 2015-10-20 |
| CN102264694B (zh) | 2015-11-25 |
| WO2010043904A2 (en) | 2010-04-22 |
| WO2010043904A3 (en) | 2010-09-16 |
| CA2740559A1 (en) | 2010-04-22 |
| JP2012505872A (ja) | 2012-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ592686A (en) | Process for the preparation of vorinostat from aniline, hydroxylamine and suberic acid starting materials | |
| MX2009004233A (es) | Compuestos de biaril eter urea. | |
| ZA201403565B (en) | N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides | |
| MD20120050A2 (en) | New agomelatine cocrystals, process for their preparation and pharmaceutical compositions containing them | |
| PE20091888A1 (es) | Inhibidores de catepsina c | |
| NZ619076A (en) | Isoxazolines as inhibitors of fatty acid amide hydrolase | |
| JP2010509220A5 (enExample) | ||
| JP2016539951A (ja) | Ｎ−アシル酸性アミノ酸又はその塩の製造方法及びその使用 | |
| AR079404A1 (es) | Antagonista dp2 y composicion farmaceutica, uso y proceso de preparacion | |
| BR112014003602A2 (pt) | método para a produção de um sal de metionina | |
| NZ600786A (en) | Proteasome inhibitors and processes for their preparation, purification and use | |
| RU2014123997A (ru) | Стабилизированные растворы холина и способы их получения | |
| PH12012501757A1 (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| MX2012008413A (es) | Composicion novedosa de retigabina. | |
| TNSN07228A1 (en) | Manufacture process of organic compounds | |
| CN104447412A (zh) | 一种异氰酸酯的制备方法 | |
| MX2013000433A (es) | Sintesis de ciclopentaquinazolinas. | |
| EP2733134A3 (en) | Alternative to tetrazene | |
| BRPI0909752B8 (pt) | processos para a produção de sulfonilpirróis como inibidores de hdac e de uma composição farmacêutica compreendendo os mesmos | |
| JO3684B1 (ar) | صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك | |
| UA112407C2 (uk) | Співкристали агомелатіну, спосіб їх виготовлення і фармацевтичні композиції, що їх містять | |
| UA94043C2 (ru) | Применение агомелатина в получении лекарственных средств, предназначенных для лечения перивентрикулярной лейкомалации | |
| TW200635880A (en) | Manufacture process of organic compounds | |
| HUP0302174A2 (hu) | Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenilalanin (Nateglinid) és kristálymódosulatainak előállítására, valamint a G kristálymódosulata | |
| NZ593585A (en) | Crystalline forms of vorinostat (suberoylanilide hydroxamic acid) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 14 OCT 2016 BY DENNEMEYER + CO Effective date: 20130926 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2017 BY COMPUTER PACKAGES INC Effective date: 20160920 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2018 BY RENEWALS TEAM Effective date: 20171006 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2019 BY RENEWALS TEAM Effective date: 20180916 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2020 BY RENEWALS TEAM Effective date: 20191007 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 OCT 2021 BY RENEWALS TEAM Effective date: 20201010 |
|
| LAPS | Patent lapsed |